GREY:IPHAF - Post by User
Post by
ngerritson Jun 13, 2010 4:18pm
566 Views
Post# 17184535
bio run up stocks to watch
bio run up stocks to watch
Jun 13th, 2010 by BioRunUp
QCOR - With the FDA’s recent surprise extension, it will be very interesting to see how the market reacts. As I wrote about in an article late Friday afternoon, the wording of QCOR’s press release seemed to hint at the fact that the FDA was very close to approving the sNDA for Acthar. Any dip in price over this week will provide an excellent opportunity to get in for September’s run-up. September’s target price – $12. Unfortunately for my June $12.50 options gamble, they will likely be rendered worthless when trading opens.
ISA.TO (IPHAF) - Isotechnika continues to be a ‘sleeper’ play, as the FDA’s June 28th advisory panel quickly approaches for its drug voclosprin (which also has a 6 month priority review). The price rose last week from $.26 to $.285, but I feel it has more room to run before the panel notes are released. Target price is around $.40 – $.45 There was an excellent post in the comments section of the linked article on investing in foreign stocks. Click here to view it. (Thanks indie!)